ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression, accounting for about 15-20% of breast cancers [1].